Vicarious Surgical (RBOT) Net Cash Flow (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Net Cash Flow came in at -$746000.0 in Q3 2025, up 94.34% year-on-year from -$383862.7 in Q3 2024, and down 156.9% on a QoQ basis from $1.3 million in Q2 2025.
Vicarious Surgical (RBOT) Net Cash Flow (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Net Cash Flow data on file, last reported at -$746000.0 in Q3 2025.
- On a quarterly basis, Net Cash Flow rose 94.34% year-over-year to -$746000.0 in Q3 2025; TTM through Dec 2025 was -$6.6 million, a 84.74% increase from a year earlier, with the FY2024 full-year figure at -$43.1 million, up 32.03% from the prior year.
- Net Cash Flow for Q3 2025 stood at -$746000.0, down from $1.3 million in the prior quarter.
- Over the last five years, Net Cash Flow for RBOT reached as high as $177.3 million in Q3 2021 and fell as low as -$62.1 million in Q1 2023.
- Historically, Net Cash Flow has averaged -$678157.9 across 5 years, with a median of -$10.6 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 14969.13% in 2021 and fell as far as 1112.11% in 2021.
- Year by year, Net Cash Flow stood at -$11.1 million in 2021, then climbed by 4.66% to -$10.6 million in 2022, then surged by 40.59% to -$6.3 million in 2023, then jumped by 142.41% to $2.7 million in 2024, then slumped by 127.96% to -$746000.0 in 2025.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$746000.0 in Q3 2025, $1.3 million in Q2 2025, and -$7.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -746,000.00 |
| Sep 30, 2025 | -746,000.00 |
| Jun 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | -7.14 Mn |
| Mar 31, 2025 | -7.14 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Mar 31, 2024 | -14.60 Mn |
| Mar 31, 2024 | -14.60 Mn |
| Dec 31, 2023 | -6.29 Mn |
| Dec 31, 2023 | -6.29 Mn |
| Sep 30, 2023 | 26.31 Mn |
| Sep 30, 2023 | 26.31 Mn |
| Jun 30, 2023 | -21.28 Mn |
| Jun 30, 2023 | -21.28 Mn |